MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Những quyển sách tương tự

• Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
  Bằng: Zhang, Zhe, et al.
  Được phát hành: (2019)
• EGFR/Met association regulates EGFR TKI resistance in breast cancer
  Bằng: Mueller, Kelly L, et al.
  Được phát hành: (2010)
• MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
  Bằng: Presutti, Dario, et al.
  Được phát hành: (2015)
• Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?
  Bằng: Kanemura, Hiroaki, et al.
  Được phát hành: (2020)
• Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer
  Bằng: WANG, CHENGDE, et al.
  Được phát hành: (2015)